Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
30.0%
% of FBT's 31 holdings also in GNOM
22.0%
% of GNOM's 41 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 4.3% | 5.4% | 4.3% |
 |
BIONTECH SE SPONSORED ADR | 3.4% | 4.1% | 3.4% |
|
SAREPTA THERAPEUTICS INC | 3.3% | 3.6% | 3.3% |
|
ILLUMINA INC | 3.3% | 3.8% | 3.3% |
|
BIOMARIN PHARMACEUTICAL INC | 3.2% | 3.6% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to GNOM
|
EXELIXIS INC | 4.5% |
|
CORCEPT THERAPEUTICS INC | 4.1% |
|
ACADIA PHARMACEUTICALS INC | 3.9% |
 |
ARGENX SE ADR | 3.8% |
|
REPLIGEN CORP | 3.8% |
|
NEUROCRINE BIOSCIENCES INC | 3.7% |
|
INTRA-CELLULAR THERAPIES INC | 3.7% |
|
CATALYST PHARMACEUTICAL PART | 3.6% |
|
WATERS CORP | 3.6% |
 |
ALKERMES PLC | 3.6% |
FBT Underweight Relative to GNOM
 |
ENI SPA-SPONSORED ADR | -7.7% |
|
VERACYTE INC | -5.1% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -4.2% |
|
BIO-TECHNE CORPORATION | -4.2% |
|
QIAGEN NV | -4.2% |
|
AGILENT TECHNOLOGIES INC | -4.0% |
|
CRISPR THERAPEUTICS AG | -3.6% |
|
BEAM THERAPEUTICS, INC. | -3.6% |
|
ULTRAGENYX PHARMACEUTICAL IN | -3.2% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.1% |